Back to R&D main

Evaluation and cost/benefit analysis of Rhinogard® vaccine in preventing Bovine Respiratory Disease in export cattle

Project start date: 01 January 2000
Project end date: 01 April 2002
Publication date: 01 April 2002
Project status: Completed
Download Report (0.2 MB)

Summary

This review provides a brief overview of:
bovine respiratory disease (BRD), including causes of this condition and the impact of this disease in Australia's live cattle export trade;
bovine herpesvirus 1, an important contributor to BRD, and the virus associated with infectious bovine rhinotracheitis in cattle; and
Rhinogard, the first respiratory vaccine of cattle registered for use in Australia
​The review also provides a brief summary of lessons learned from international best practice in the use of vaccines for BRD control.

More information

Project manager: Sharon Dundon
Primary researcher: AusVet Animal Health Services